A method for treating cancer cells is provided comprising directly or systemically administering a therapeutically effective dose of an attenuated measles virus. In one embodiment, the therapeutically effective dose is from about 10.sup.3 pfus to about 10.sup.12 pfus and is delivered by direct injection into a group of cancer cells or via intravenous injection.